Oregon Medicaid spending on GLP-1 drugs

How much did Oregon Medicaid spend on GLP-1 drugs like Ozempic and Mounjaro in 2025?

Pharmacies were reimbursed at least $67.4 million for GLP-1 drugs paid through Oregon Medicaid in 2025, across at least 72,793 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 106 rows of 290, so these figures are floors.

Pharmacies were reimbursed at least $16.6 million for GLP-1 drugs paid through Oregon Medicaid in 2026 (quarter 1 only, as posted so far), across at least 17,838 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 32 rows of 81, so these figures are floors.

By year and ingredient

2020at least $1,029,624No dataat least $7,248,391at least $9,797,505at least $2,363,848at least $38,501at least $66,693Suppressedat least $20,544,561
2021at least $2,241,193No dataat least $6,898,846at least $16,548,199at least $1,812,297at least $51,211$64,338at least $30,049at least $27,646,134
2022at least $6,384,768at least $27,654at least $6,285,806at least $19,901,213at least $1,384,563at least $10,566$67,777Suppressedat least $34,062,347
2023at least $14,039,160at least $958,027at least $5,512,605at least $23,280,072at least $1,445,457Suppressed$67,345at least $12,531at least $45,315,196
2024at least $26,407,488at least $2,367,898at least $2,390,283at least $21,520,809at least $1,257,104No data$54,725Suppressedat least $53,998,307
2025at least $30,461,245at least $8,830,363at least $3,801,673at least $24,030,074at least $216,438No dataat least $11,499Suppressedat least $67,351,293
2026 (Q1)at least $6,519,923at least $3,938,952at least $785,232$5,318,103No dataNo dataSuppressedSuppressedat least $16,562,209

By product, 2025

Ozempicat least $27,579,361at least 28,2857 of 31
Rybelsusat least $1,016,840at least 8228 of 23
Wegovyat least $1,865,044at least 1,46020 of 40
Mounjaroat least $5,556,703at least 5,4245 of 50
Zepboundat least $3,273,659at least 3,14718 of 37
Liraglutide (generic name listing)at least $3,794,402at least 8,93319 of 44
SaxendaSuppressedSuppressed1 of 1
Victozaat least $7,272at least 1311 of 12
Trulicityat least $24,030,074at least 24,4264 of 36
Bydureonat least $216,438at least 2692 of 4
ByettaSuppressedSuppressed3 of 3
Exenatide (generic name listing)SuppressedSuppressed1 of 1
Soliquaat least $11,499at least 143 of 4
XultophySuppressedSuppressed4 of 4

By quarter, 2025

Q1 2025at least $15,779,199at least 16,64628 of 68
Q2 2025at least $16,542,123at least 17,81527 of 74
Q3 2025at least $17,020,135at least 18,45227 of 74
Q4 2025at least $18,009,836at least 19,88024 of 74

By quarter, 2026 (posted so far)

Q1 2026at least $16,562,209at least 17,83832 of 81

The amounts are CMS’s “Total Amount Reimbursed” field. CMS’s data dictionary for State Drug Utilization Data says of it:

“This total is not reduced or affected by Medicaid rebates paid to the state. This amount represents both the Federal and State Reimbursement and is inclusive of dispensing fees.”

Its prescription count is “The number of prescriptions reimbursed (by the Medicaid Program ONLY) to pharmacists for the (11-digit NDC) drug for the period covered.”

CMS suppresses some rows (its “Suppression Used” field is true and the counts and amounts are left blank). Here a suppressed row is never counted as zero: a figure that includes suppressed rows is shown as “at least” the sum of the rows CMS did publish, and a figure where every row is suppressed is shown as “Suppressed.” The “Rows suppressed” column gives the count. Where many rows are suppressed, the published sum can be well below the full amount, so floors for different states are not directly comparable.

Fee-for-service and managed care rows are added together. Other states: Medicare and Medicaid spending on GLP-1 drugs.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.